Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 166: 677-686, 2021 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-33152359

RESUMO

The object of this study was to utilize agro-industrial waste Corchorus olitorius stems (molokhia stems, MS) as substrate, for Aspergillus niger MK981235 xylanase production and as source of biologically active xylooligosaccharides (XOS). This study succeeded in utilization of Aspergillus niger MK981235 xylanase under different saccharification conditions designed by central composite design (CCD) for extraction of 15 biologically active XOS (anti-hepatotoxic, antioxidant, hypocholesterolemic and prebiotic) with different monosaccharides constituents composition and percent. A. niger MK981235 xylanase showed the highest activity 6.60 U·ml-1 at 50 °C with 1.5% xylan. The kinetics included Km and Vmax were determined to be 6.67 mg·ml-1 and 20 µmol·ml-1·min-1, respectively. Moreover, A. niger MK981235 xylanase thermodynamics Ea (activation energy) and Ed (activation energy of denaturation) were determined to be 21.95 and 39.51 KJ·mol-1, respectively. The highest prebiotic effect (growth promation) was exerted by the central MS XOS on Lactobacillus plantarum and Lactobacillus rhamnosus (125 and 135.3%, respectively). Also, the central MS XOS, exerted the highest cholesterol reduction and antioxidant activities 74.7 and 92%, respectively, showed remarkable in vivo protective role against the hepatic toxicity of lithium carbonate evaluated by changes in body weight, liver function markers (AST, ALT, Alb, total bilirubin) and tissue makers (MDA and GSH).


Assuntos
Antioxidantes/química , Endo-1,4-beta-Xilanases/metabolismo , Proteínas Fúngicas/metabolismo , Glucuronatos/química , Oligossacarídeos/química , Caules de Planta/química , Prebióticos , Animais , Anticolesterolemiantes/química , Anticolesterolemiantes/farmacologia , Anticolesterolemiantes/uso terapêutico , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Aspergillus niger/enzimologia , Biodegradação Ambiental , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Corchorus/química , Endo-1,4-beta-Xilanases/química , Proteínas Fúngicas/química , Glucuronatos/metabolismo , Glucuronatos/farmacologia , Glucuronatos/uso terapêutico , Resíduos Industriais , Lactobacillus/metabolismo , Lítio/toxicidade , Fígado/efeitos dos fármacos , Masculino , Oligossacarídeos/metabolismo , Oligossacarídeos/farmacologia , Oligossacarídeos/uso terapêutico , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA